|
ZNF665 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82166000000095E-05 |
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.035500E-04 |
| Normal-vs-Stage2 |
6.172000E-02 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
5.924100E-02 |
| Stage1-vs-Stage2 |
5.602000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
7.927200E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
7.428400E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.006100E-04 |
| Normal-vs-AfricanAmerican |
1.487400E-01 |
| Normal-vs-Asian |
2.334000E-01 |
| Caucasian-vs-AfricanAmerican |
2.618600E-01 |
| Caucasian-vs-Asian |
2.085600E-01 |
| AfricanAmerican-vs-Asian |
9.943800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.221500E-03 |
| Normal-vs-Female |
8.006100E-04 |
| Male-vs-Female |
7.965800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.211200E-01 |
| Normal-vs-Extreme_Weight |
1.800820E-03 |
| Normal-vs-Obese |
1.465760E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
9.250800E-01 |
| Normal_Weight-vs-Obese |
9.884200E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
8.839200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.782200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.985610E-02 |
| Normal-vs-Age(61-80Yrs) |
5.425400E-04 |
| Normal-vs-Age(81-100Yrs) |
2.105900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.576400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.562400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.405800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.170200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.622800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.952600E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
5.993200E-01 |
| Normal-vs-Grade 3 |
5.057400E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
8.202600E-01 |
| Grade 2-vs-Grade 4 |
5.993200E-01 |
| Grade 3-vs-Grade 4 |
5.057400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.422300E-04 |
| Normal-vs-N1 |
3.618200E-02 |
| N0-vs-N1 |
4.315200E-01 |
|
|
